Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-31T17:28:56.441Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroimaging of depression in Parkinson's disease: a review

Published online by Cambridge University Press:  02 September 2013

Marcos Hortes N. Chagas ,
Ila M.P. Linares ,
Giovana Jorge Garcia ,
Jaime E.C. Hallak ,
Vitor Tumas  and
José Alexandre S. Crippa
Marcos Hortes N. Chagas*
Affiliation:
Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, and INCT Translational Medicine (CNPq), São Paulo, Brazil
Ila M.P. Linares
Affiliation:
Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, and INCT Translational Medicine (CNPq), São Paulo, Brazil
Giovana Jorge Garcia
Affiliation:
Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, and INCT Translational Medicine (CNPq), São Paulo, Brazil
Jaime E.C. Hallak
Affiliation:
Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, and INCT Translational Medicine (CNPq), São Paulo, Brazil
Vitor Tumas
Affiliation:
Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, and INCT Translational Medicine (CNPq), São Paulo, Brazil
José Alexandre S. Crippa
Affiliation:
Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, and INCT Translational Medicine (CNPq), São Paulo, Brazil
*
Correspondence should be addressed to: Marcos Hortes N. Chagas, Hospital das Clínicas, Terceiro Andar, Av. Bandeirantes, 3900, 14048-900-Ribeirão Preto, SP, Brazil. Phone: +55-16-360227031; Fax: +55-16-36022544. Email: [email protected].
Get access

Abstract

Background:

Depression is the most common psychiatric manifestation in patients with Parkinson's disease (PD). In addition, depressive symptoms may be considered to be a prodromal manifestation of PD. In recent years, the association between PD and depression has been the focus of neuroimaging studies using functional and structural techniques.

Methods:

The aim of this study was to review the main neuroimaging studies assessing the comorbidity between depression and PD. Literature searches were conducted to find the major neuroimaging studies that consider primarily the comorbidity between depression and PD using the indices Web of Science and Lilacs.

Results:

In total, 296 papers were identified, and 18 of these studies were selected for the current review. The principal neuroimaging technique used was SPECT. The structural neuroimaging studies that have evaluated the impact of current or previous bouts of depression on the neurodegenerative process of PD are scarce and inclusive. The instruments that were used to evaluate depression differed among the studies. Several brain regions appear to be involved in depression, particularly the limbic system and the basal ganglia. In addition, the serotonergic, dopaminergic, and noradrenergic systems also appear to be associated with depressive symptoms in PD.

Conclusion:

Several brain regions and neurotransmitter systems are involved in depression in PD; however, the variety of criteria used to evaluate depressive symptoms precludes more specific conclusions.

Keywords

neuroimagingParkinson’s diseasedepression
Type
Review Article
Information
International Psychogeriatrics , Volume 25 , Issue 12 , December 2013 , pp. 1953 - 1961
Copyright
Copyright © International Psychogeriatric Association 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ballanger, B.et al. (2012). Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease. Movement Disorders, 27, 84–89.CrossRefGoogle ScholarPubMed
Berg, D.et al. (1999). Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. Journal of Neurology, 246, 1186–1193.CrossRefGoogle ScholarPubMed
Bohnen, N. I., Kaufer, D. I., Hendrickson, R., Constantine, G. M., Mathis, C. A. and Moore, R. Y. (2007). Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia. Journal of Neurology Neurosurgery and Psychiatry, 78, 641–643.CrossRefGoogle ScholarPubMed
Boileau, I.et al. (2008). Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB. Movement Disorders, 23, 1776–1780.CrossRefGoogle ScholarPubMed
Braak, H., Del Tredici, K., Rub, U., de Vos, R. A., Jansen Steur, E. N. and Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging, 24, 197–211.CrossRefGoogle ScholarPubMed
Cardoso, E. F.et al. (2009). Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus. Neuroimage, 47, 467–472.CrossRefGoogle ScholarPubMed
Chagas, M. H., Sanches, R. F., Tumas, V., Marchi, K. C. and Tirapelli, C. R. (2011). Quality of life and depressive symptoms in Parkinson's disease. Revista Brasileira de Psiquiatria, 33, 99–101.CrossRefGoogle ScholarPubMed
Feldmann, A.et al. (2008). Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study. Movement Disorders, 23, 42–46.CrossRefGoogle ScholarPubMed
Felicio, A. C.et al. (2010). Higher dopamine transporter density in Parkinson's disease patients with depression. Psychopharmacology, 211, 27–31.CrossRefGoogle ScholarPubMed
Fibiger, H. C. (1984). The neurobiological substrates of depression in Parkinson's disease: a hypothesis. Canadian Journal of Neurological Sciences, 11, 105–107.CrossRefGoogle ScholarPubMed
Hesse, S.et al. (2009). Monoamine transporter availability in Parkinson's disease patients with or without depression. European Journal of Nuclear Medicine and Molecular Imaging, 36, 428–435.CrossRefGoogle ScholarPubMed
Imamura, K., Okayasu, N. and Nagatsu, T. (2011). The relationship between depression and regional cerebral blood flow in Parkinson's disease and the effect of selegiline treatment. Acta Neurologica Scandinavica, 124, 28–39.CrossRefGoogle ScholarPubMed
Leentjens, A. F., Van den Akker, M., Metsemakers, J. F., Lousberg, R. and Verhey, F. R. (2003). Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Movement Disorders, 18, 414–418.CrossRefGoogle ScholarPubMed
Li, W., Liu, J., Skidmore, F., Liu, Y., Tian, J. and Li, K. (2010). White matter microstructure changes in the thalamus in Parkinson disease with depression: a diffusion tensor MR imaging study. American Journal of Neuroradiology, 31, 1861–1866.CrossRefGoogle ScholarPubMed
Martinez-Martin, P.et al. (2007). Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Movement Disorders, 22, 1623–1629.CrossRefGoogle Scholar
Matsui, H., Nishinaka, K., Oda, M., Komatsu, K., Kubori, T. and Udaka, F. (2006). Minor depression and brain perfusion images in Parkinson's disease. Movement Disorders, 21, 1169–1174.CrossRefGoogle ScholarPubMed
Matsui, H.et al. (2007). Depression in Parkinson's disease: diffusion tensor imaging study. Journal of Neurology, 254, 1170–1173.CrossRefGoogle ScholarPubMed
Mayberg, H. S. and Solomon, D. H. (1995). Depression in Parkinson's disease: a biochemical and organic viewpoint. Advances in Neurology, 65, 49–60.Google ScholarPubMed
Mayberg, H. S.et al. (1990). Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Annals of Neurology, 28, 57–64.CrossRefGoogle ScholarPubMed
Mayeux, R. (1990). The “serotonin hypothesis” for depression in Parkinson's disease. Advances in Neurology, 53, 163–166.Google Scholar
Mayeux, R., Stern, Y., Cote, L. and Williams, J. B. (1984). Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology, 34, 642–646.CrossRefGoogle ScholarPubMed
Nakabayashi, T. I. K., Chagas, M. H. N., Correa, A. C. L., Tumas, V., Loureiro, S. R. and Crippa, J. A. S. (2008). Prevalence of depression in Parkinson's disease. Revista de Psiquiatria Clinica, 35, 219–227.CrossRefGoogle Scholar
Palhagen, S. E., Ekberg, S., Walinder, J., Granerus, A. K. and Granerus, G. (2009). HMPAO SPECT in Parkinson's disease (PD) with major depression (MD) before and after antidepressant treatment. Journal of Neurology, 256, 1510–1518.CrossRefGoogle ScholarPubMed
Parkinson, J. (2002). An essay on the shaking palsy. 1817. Journal of Neuropsychiatry and Clinical Neurosciences, 14, 223–236; discussion 222.CrossRefGoogle ScholarPubMed
Paulus, W. and Jellinger, K. (1991). The neuropathologic basis of different clinical subgroups of Parkinson's disease. Journal of Neuropathology and Experimental Neurology, 50, 743–755.CrossRefGoogle ScholarPubMed
Rektorova, I., Srovnalova, H., Kubikova, R. and Prasek, J. (2008). Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease. Movement Disorders, 23, 1580–1587.CrossRefGoogle Scholar
Remy, P., Doder, M., Lees, A., Turjanski, N. and Brooks, D. (2005). Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain, 128, 1314–1322.CrossRefGoogle ScholarPubMed
Schrag, A. (2004). Psychiatric aspects of Parkinson's disease: an update. Journal of Neurology, 251, 795–804.CrossRefGoogle ScholarPubMed
Schuurman, A. G.et al. (2002). Increased risk of Parkinson's disease after depression: a retrospective cohort study. Neurology, 58, 1501–1504.CrossRefGoogle ScholarPubMed
Surdhar, I., Gee, M., Bouchard, T., Coupland, N., Malykhin, N. and Camicioli, R. (2012). Intact limbic-prefrontal connections and reduced amygdala volumes in Parkinson's disease with mild depressive symptoms. Parkinsonism and Related Disorders, 18, 809–813.CrossRefGoogle ScholarPubMed
Walter, U., Hoeppner, J., Prudente-Morrissey, L., Horowski, S., Herpertz, S. C. and Benecke, R. (2007). Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain, 130, 1799–1807.CrossRefGoogle ScholarPubMed
Weintraub, D.et al. (2005). Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. Journal of Nuclear Medicine, 46, 227–232.Google ScholarPubMed
Wu, H., Lou, C., Huang, Z. and Shi, G. (2011). SPECT imaging of dopamine transporters with (99m)Tc-TRODAT-1 in major depression and Parkinson's disease. Journal of Neuropsychiatry Clinical Neurosciences, 23, 63–67.CrossRefGoogle ScholarPubMed